ENDOGENEX
Endogenex develops an endoscopic procedure to help patients with Type 2 Diabetes regain control of their blood glucose levels.
ENDOGENEX
Social Links:
Industry:
Health Care Medical Device Therapeutics
Founded:
2017-01-01
Address:
Plymouth, Minnesota, United States
Country:
United States
Website Url:
http://www.endogenex.com
Total Employee:
11+
Status:
Active
Contact:
+1 763 251-6820
Email Addresses:
[email protected]
Total Funding:
25 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud Google Cloud Iowa
Similar Organizations
Arsenal Medical
Arsenal Medical develops novel products that improve local therapy for injuries and diseases.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sante Ventures
Sante Ventures investment in Series A - Endogenex
Southeast Minnesota Capital Fund
Southeast Minnesota Capital Fund investment in Pre Seed Round - Endogenex
Official Site Inspections
http://www.endogenex.com
- Host name: 202.52.75.34.bc.googleusercontent.com
- IP address: 34.75.52.202
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Endogenex"
About Us - Endogenex
Endogenex, in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). ... Prior to joining the team, Stacey was the Chief Commercial Officer at Butterfly Network, leading …See details»
ReCET Treatment by Endogenex
Signaling a new era in type 2 diabetes therapy. Research shows that signaling from the small intestine (specifically the duodenum) is a key regulator of metabolic function, including blood sugar management in the body. 5,6 When …See details»
Endogenex - Crunchbase Company Profile & Funding
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels. Established in 2017, Endogenex has developed a novel therapy that utilizes pulsed electric fields to …See details»
Endogenex Company Profile 2024: Valuation, Funding …
Endogenex General Information Description. Developer of a novel endoscopic procedure designed to treat diabetes. The company offers a medical device that provides patients with a way to regain control of their blood glucose levels, …See details»
Endogenex - LinkedIn
Endogenex’s innovations focus on resetting the body’s metabolic signaling system by harnessing its natural regenerative capabilities to improve metabolic function. Through the development of ...See details»
Endogenex™ Appoints Medical Device Executive, Stacey Pugh, …
Mar 23, 2023 In this role Stacey will lead the organization as it expands its clinical initiatives evaluating the novel ReCETâ„¢ Procedure for the treatment of Type 2 Diabetes. ...See details»
Endogenex - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Endogenexâ„¢ Appoints Christopher Sorli as Chief Medical Officer
May 18, 2023 "We are honored to have Dr. Sorli join the Endogenex team and bring his expertise of patient care, clinical research, and leadership to our organization," said Stacey …See details»
Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study
Jan 30, 2024 Endogenex, Inc., a clinical stage medical device company dedicated to improving outcomes in patients with Type 2 Diabetes (T2D), announced that the U.S. Food and Drug …See details»
Endogenex™ Appoints Medical Device Executive, …
March 23, 2023 – Endogenex, Inc., a clinical stage medical device company, is proud to announce the addition of Stacey Pugh as Chief Executive Officer (CEO). In this role Stacey will lead the organization as it expands its clinical initiatives …See details»
Endogenex - Contacts, Employees, Board Members, Advisors
Organization. Endogenex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contacts 15. About. Endogenex has 5 current employee profiles, including …See details»
Endogenex™ Announces $88 Million Series C Financing to …
Jun 25, 2024 Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes, announced it has closed an oversubscribed …See details»
Endogenexâ„¢ Appoints Christopher Sorli as Chief Medical Officer
May 18, 2023 – Endogenex, Inc., a clinical stage medical device company, is proud to announce the addition of Christopher Sorli, MD, PhD, as Chief Medical Officer (CMO). Dr. ... Dr. Sorli join …See details»
Intern Confirms Passion for Med Tech with Endogenex - SciTech
Oct 25, 2021 This April, medical device startup Endogenex secured a new round of funding to further their work in developing therapies for GI and metabolic diseases processes. One of …See details»
Clinical Providers - Endogenex
Endogenex is committed to improving the treatment of type 2 diabetes. The ReCET Procedure is investigational and currently being evaluated in clinical study. Endogenex is focused on …See details»
Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study
Jan 30, 2024 Endogenex is a privately held, clinical stage company headquartered in Minneapolis, MN. Endogenex was founded, in partnership with Mayo Clinic, to develop …See details»
Endogenex™ Announces Presentation of First Human Clinical …
May 4, 2023 Endogenex is a privately held, clinical stage company headquartered in Minneapolis, MN. Endogenex was founded, in partnership with Mayo Clinic, to develop …See details»
Endogenex™ Announces $88 Million Series C Financing to …
Jun 25, 2024 Endogenex, founded in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). The company's innovations focus …See details»
Endogenex™ Announces First Patient Enrolled in the ReCET …
Oct 15, 2024 About Endogenex Endogenex, founded in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). The company's …See details»